迪立舒和典必殊滴眼液对白内障超声乳化手术后抗炎疗效的比较观察  

Compound Gentamicin-Fluorometholone vs Tobramycin-Dexamethasone Eyedrops after Cataract Phacoemulsification:A Clinical Comparative Study

作　　者：姚毅[1] 张卯年[1] 刘玉凤[1] 王瑛[1] 杨丙建[1] 

机构地区：[1]解放军总医院,北京100853

出　　处：《中华医院感染学杂志》2007年第1期35-37,共3页Chinese Journal of Nosocomiology

摘　　要：目的观察迪立舒和典必殊滴眼液对白内障超声乳化术后抗炎治疗的效果。方法对60例(60眼)白内障常规超声乳化联合人工晶状体植入手术的患者随机分为两组:迪立舒组(30例)和典必殊组(30例),手术后前3天,滴眼6次/d,第3天后改为4次/d,术后第3天及第7天观察两组患者的临床症状和体征。结果两组对前房内炎症反应的控制效果相同。结论迪立舒和典必殊相比,抗菌消炎效果相同,不良反应少;均可作为白内障超声乳化手术后的常规用药。OBJECTIVE To investigate influence of compound gentamicin-fluorometholone （GentaFluoro） and tobramycin-dexamethasone （TobraDex） eyedrops for treating ocular inflammation after cataract phacoemulsification. METHODS Sixty eyes in 60 patients after cataract phacoemulsification were equally randomized into two groups, such as GentaFluoro group and TobraDex group according to order of operation. Two groups were used respectively the two sort of eyedrops ： GentaFluoro and TobraDex were used 6 times per day during first three days after the operation, later four days were four times per day. RESULTS GentaFluoro group and TobraDex group had identical results in controlling inflammation of anterior chamber. CONCLUSIONS The effects of GentaFluoro and TobraDex eyedrops for treating ocular inflammation after phacoemulsification are reliable.

关 键 词：迪立舒 典必殊 滴眼液 白内障 超声乳化 

分 类 号：R776.1[医药卫生—眼科]